| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | See Remark | SVP And General Counsel +1 more
2 companies
Matsuda Masaru is a See Remarks at Arcutis Biotherapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $5.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 1,434 | $15.83 | $22,695.79 | -3.8% | -52.5% | -25.6% | |
| Nov 21, 2022 | ARQT Arcutis Biotherapeutics, Inc. | See Remark | Sell | 1,720 | $18.19 | $31,288.86 | -8.1% | -11.1% | -89.6% | |
| Jun 2, 2022 | ARQT Arcutis Biotherapeutics, Inc. | SVP And General Counsel | Sell | 1,795 | $19.73 | $35,418.58 | -9.9% | +31.0% | -60.1% |